Form 4: Humana Inc. President & CEO James A. Rechtin Reports Stock Purchase
SEC Form 4
James A. Rechtin, President & CEO of Humana Inc., reports the purchase of 6,530 shares of Humana common stock at an average price of $229.2471.
Summary
- On May 14, 2025, James A. Rechtin, President & CEO of Humana Inc., purchased 6,530 shares of Humana common stock.
- The average price paid per share was $229.2471.
- Following the transaction, Rechtin directly and indirectly owns 30,474 shares.
- These holdings include shares held in revocable trusts and restricted stock units.
- Rechtin also holds options to purchase 29,230 shares (granted 1/8/2024) and 15,772 shares (granted 2/21/2024) of Humana common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's stock purchase is a positive signal, but it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- The CEO's purchase of company stock may signal confidence in the company's future performance.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued.
Stakeholder Impact
- The CEO's stock purchase could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 01/08/2024 | Grant date of incentive and non-qualified stock options for 29,230 shares, vesting in three annual increments from 1/8/25 to 1/8/27. |
| 02/21/2024 | Grant date of incentive and non-qualified stock options for 15,772 shares, vesting in three annual increments from 2/21/25 to 2/21/27. |
| 01/08/2025 | First vesting date for 33% of restricted stock units granted on 1/8/2024. |
| 05/14/2025 | Date of stock purchase transaction. |
| 05/16/2025 | Date of Form 4 filing. |
| 01/08/2026 | Second vesting date for 33% of restricted stock units granted on 1/8/2024. |
| 02/21/2027 | Final vesting date for incentive and non-qualified stock options granted on 2/21/2024. |
| 01/08/2027 | Final vesting date for incentive and non-qualified stock options granted on 1/8/2024 and final vesting date for 33% of restricted stock units granted on 1/8/2024. |
| 01/08/2031 | Expiration date for options granted on 1/8/2024. |
| 02/21/2031 | Expiration date for options granted on 2/21/2024. |
Keywords
Humana, Rechtin, Insider Trading, Stock Purchase, Form 4, Beneficial Ownership, Common Stock, Options, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.